» Authors » Felix Hohendanner

Felix Hohendanner

Explore the profile of Felix Hohendanner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 457
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Dehe L, Hohendanner F, Gultekin E, Werth G, Wutzler A, Bender T
Aerosp Med Hum Perform . 2023 Feb; 94(3):102-106. PMID: 36829278
Chronic obstructive pulmonary disease (COPD) is highly prevalent and often associated with chronic hypoxia. Previous studies have shown alterations of cerebral oxygenation and cardiac repolarization in COPD patients (GOLD stage...
12.
Primessnig U, Deissler P, Wakula P, Tran K, Hohendanner F, von Lewinski D, et al.
Front Cardiovasc Med . 2022 Jul; 9:859014. PMID: 35865376
Background: Although the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril/valsartan started a new era in heart failure (HF) treatment, less is known about the tissue-level effects of the drug on the atrial...
13.
Parwani A, Hohendanner F, Kluck A, Blaschke F, Pieske B, Boldt L
Adv Clin Exp Med . 2022 Mar; 31(7):715-721. PMID: 35302302
Background: Radiofrequency (RF) ablation is a commonly used method of atrial fibrillation (AF) treatment. High-power short-duration (HPSD) ablation has been suggested as a method to reduce procedure times whilst creating...
14.
Lacour P, Dang P, Heinzel F, Parwani A, Bahr F, Kucher A, et al.
Heart Rhythm . 2021 Nov; 19(3):372-380. PMID: 34767986
Background: Recent case reports and small studies have reported activation of the magnet-sensitive switches in cardiovascular implantable electronic devices (CIEDs) by the new iPhone 12 series, initiating asynchronous pacing in...
15.
Dimai S, Semmler L, Prabhu A, Stachelscheid H, Huettemeister J, Klaucke S, et al.
PLoS One . 2021 Aug; 16(8):e0255976. PMID: 34411149
Background: Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-2 mediated coronavirus disease (COVID19) and mortality is particularly high in these patients. The mechanistic role of the COVID19 associated...
16.
Bode D, Semmler L, Oeing C, Alogna A, Schiattarella G, Pieske B, et al.
Int J Mol Sci . 2021 Jun; 22(11). PMID: 34073033
Atrial fibrillation (AF) is the most common sustained (atrial) arrhythmia, a considerable global health burden and often associated with heart failure. Perturbations of redox signalling in cardiomyocytes provide a cellular...
17.
Hegemann N, Primessnig U, Bode D, Wakula P, Beindorff N, Klopfleisch R, et al.
ESC Heart Fail . 2021 May; 8(4):3130-3144. PMID: 34002482
Aims: Heart failure with preserved ejection fraction (HFpEF) is frequently (30%) associated with right ventricular (RV) dysfunction, which increases morbidity and mortality in these patients. Yet cellular mechanisms of RV...
18.
Blaschke F, Lacour P, Dang P, Parwani A, Hohendanner F, Walter T, et al.
ESC Heart Fail . 2021 May; 8(4):2591-2596. PMID: 33932118
Aim: Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is...
19.
Bode D, Rolim N, Guthof T, Hegemann N, Wakula P, Primessnig U, et al.
ESC Heart Fail . 2021 Mar; 8(3):1806-1818. PMID: 33768692
Aims: Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent disease. Physical exercise has been shown to alter disease progression in HFpEF. We examined cardiomyocyte Ca homeostasis and...
20.
Bode D, Semmler L, Wakula P, Hegemann N, Primessnig U, Beindorff N, et al.
Cardiovasc Diabetol . 2021 Jan; 20(1):7. PMID: 33413413
Background: Sodium-glucose linked transporter type 2 (SGLT-2) inhibition has been shown to reduce cardiovascular mortality in heart failure independently of glycemic control and prevents the onset of atrial arrhythmias, a...